{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T23:56:08Z","timestamp":1788134168520,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX001079"],"award-info":[{"award-number":["I01BX001079"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX004423"],"award-info":[{"award-number":["I01BX004423"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH-21-1-0073"],"award-info":[{"award-number":["W81XWH-21-1-0073"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007707","name":"University of California, Davis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007707","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA093373"],"award-info":[{"award-number":["P30CA093373"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009751","name":"School of Veterinary Medicine, University of California, Davis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007496","name":"Biomedical Laboratory Research and Development, VA Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.neo.2025.101181","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T04:46:26Z","timestamp":1748493986000},"page":"101181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Alteration in expression and subcellular localization of the androgen receptor- regulated FAM111A protease is associated with emergence of castration resistant prostate cancer"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8778-5020","authenticated-orcid":false,"given":"Maria Malvina","family":"Tsamouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Libertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3659-6243","authenticated-orcid":false,"given":"Maitreyee K.","family":"Jathal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blythe P.","family":"Durbin-Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford G.","family":"Tepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9244-3807","authenticated-orcid":false,"given":"Eva","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Iczkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7304-2936","authenticated-orcid":false,"given":"Paramita M.","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6458-774X","authenticated-orcid":false,"given":"Maria","family":"Mudryj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2025.101181_bib0001","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.neo.2025.101181_bib0002","article-title":"Anti-androgen receptor therapies in prostate cancer: a brief update and perspective","volume":"12","author":"Huang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neo.2025.101181_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14153744","article-title":"Advances in the current understanding of the mechanisms governing the acquisition of castration-resistant prostate cancer","volume":"14","author":"Mao","year":"2022","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.neo.2025.101181_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14174189","article-title":"Targeted approaches in metastatic castration-resistant prostate cancer: which data?","volume":"14","author":"Mosillo","year":"2022","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.neo.2025.101181_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8100422","article-title":"The androgen receptor in prostate cancer: effect of structure, ligands and spliced variants on therapy","volume":"8","author":"Messner","year":"2020","journal-title":"Biomedicines."},{"key":"10.1016\/j.neo.2025.101181_bib0006","article-title":"Androgen receptor signaling and spatial chromatin organization in castration-resistant prostate cancer","volume":"9","author":"Zhou","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.neo.2025.101181_bib0007","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1677\/ERC-10-0081","article-title":"Genome-wide analysis of androgen receptor binding and gene regulation in two CWR22-derived prostate cancer cell lines","volume":"17","author":"Chen","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.neo.2025.101181_bib0008","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.cell.2018.10.019","article-title":"Genomic hallmarks and structural variation in metastatic prostate cancer","volume":"175","author":"Quigley","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.neo.2025.101181_bib0009","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1038\/s41467-019-13084-7","article-title":"The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact","volume":"10","author":"van Dessel","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2025.101181_bib0010","doi-asserted-by":"crossref","first-page":"316 e311","DOI":"10.1016\/j.clgc.2022.09.006","article-title":"How well do polygenic risk scores identify men at high risk for prostate cancer? Systematic review and meta-analysis","volume":"21","author":"Siltari","year":"2023","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.neo.2025.101181_bib0011","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ng.1104","article-title":"Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese","volume":"44","author":"Akamatsu","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neo.2025.101181_bib0012","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.eururo.2020.07.038","article-title":"Two-stage study of familial prostate cancer by whole-exome sequencing and custom capture identifies 10 novel genes associated with the risk of prostate cancer","volume":"79","author":"Schaid","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.neo.2025.101181_bib0013","first-page":"25","article-title":"Unravelling the intricate roles of FAM111A and FAM111B: from protease-mediated cellular processes to disease implications","author":"Naicker","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neo.2025.101181_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.1081166","article-title":"Functions and evolution of FAM111 serine proteases","volume":"9","author":"Welter","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.neo.2025.101181_bib0015","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.ajhg.2013.04.020","article-title":"FAM111A mutations result in hypoparathyroidism and impaired skeletal development","volume":"92","author":"Unger","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neo.2025.101181_bib0016","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050662","article-title":"FAM111 protease activity undermines cellular fitness and is amplified by gain-of-function mutations in human disease","volume":"21","author":"Hoffmann","year":"2020","journal-title":"EMBo Rep."},{"key":"10.1016\/j.neo.2025.101181_bib0017","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1210\/clinem\/dgad147","article-title":"Expanding the phenotypic spectrum of Kenny-Caffey syndrome","volume":"108","author":"Schigt","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neo.2025.101181_bib0018","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00467-016-3416-3","article-title":"Genetic causes of hypomagnesemia, a clinical overview","volume":"32","author":"Viering","year":"2017","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.neo.2025.101181_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002949","article-title":"Identification of FAM111A as an SV40 host range restriction and adenovirus helper factor","volume":"8","author":"Fine","year":"2012","journal-title":"PLoS. Pathog."},{"key":"10.1016\/j.neo.2025.101181_bib0020","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1073\/pnas.1700678114","article-title":"Triad of human cellular proteins, IRF2, FAM111A, and RFC3, restrict replication of orthopoxvirus SPI-1 host-range mutants","volume":"114","author":"Panda","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neo.2025.101181_bib0021","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2304242120","article-title":"Human FAM111A inhibits vaccinia virus replication by degrading viral protein I3 and is antagonized by poxvirus host range factor SPI-1","volume":"120","author":"Zhu","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neo.2025.101181_bib0022","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12985-021-01724-8","article-title":"IRF2 inhibits ZIKV replication by promoting FAM111A expression to enhance the host restriction effect of RFC3","volume":"18","author":"Ren","year":"2021","journal-title":"Virol. J."},{"key":"10.1016\/j.neo.2025.101181_bib0023","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/ncb2918","article-title":"Nascent chromatin capture proteomics determines chromatin dynamics during DNA replication and identifies unknown fork components","volume":"16","author":"Alabert","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neo.2025.101181_bib0024","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202302111","article-title":"FAM111A regulates replication origin activation and cell fitness","volume":"6","author":"Rios-Szwed","year":"2023","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.neo.2025.101181_bib0025","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/s41467-020-15170-7","article-title":"FAM111A protects replication forks from protein obstacles via its trypsin-like domain","volume":"11","author":"Kojima","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2025.101181_bib0026","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1038\/s41467-024-46207-w","article-title":"Dimerization-dependent serine protease activity of FAM111A prevents replication fork stalling at topoisomerase 1 cleavage complexes","volume":"15","author":"Palani","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2025.101181_bib0027","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-14054-8","article-title":"FAM111A is dispensable for electrolyte homeostasis in mice","volume":"12","author":"Ilenwabor","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neo.2025.101181_bib0028","article-title":"Study on the role and pharmacology of cuproptosis in gastric cancer","volume":"13","author":"Jiang","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neo.2025.101181_bib0029","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317711895","article-title":"Gene signature based on degradome-related genes can predict distal metastasis in cervical cancer patients","volume":"39","author":"Fernandez-Retana","year":"2017","journal-title":"Tumour. Biol."},{"key":"10.1016\/j.neo.2025.101181_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.573800","article-title":"Molecular and clinical characterization of a novel prognostic and immunologic biomarker FAM111A in diffuse lower-grade glioma","volume":"10","author":"Ji","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neo.2025.101181_bib0031","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2020.03.030","article-title":"The p14ARF tumor suppressor restrains androgen receptor activity and prevents apoptosis in prostate cancer cells","volume":"483","author":"Siddiqui","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neo.2025.101181_bib0032","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.urology.2007.05.002","article-title":"Novel p53\/p130 axis in bladder tumors","volume":"70","author":"Mudryj","year":"2007","journal-title":"Urology."},{"key":"10.1016\/j.neo.2025.101181_bib0033","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.canlet.2021.01.029","article-title":"Depletion of androgen receptor low molecular weight isoform reduces bladder tumor cell viability and induces apoptosis","volume":"504","author":"Katleba","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neo.2025.101181_bib0034","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","article-title":"TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions","volume":"14","author":"Kim","year":"2013","journal-title":"Genome Biol."},{"key":"10.1016\/j.neo.2025.101181_bib0035","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nprot.2012.016","article-title":"Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks","volume":"7","author":"Trapnell","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neo.2025.101181_bib0036","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1158\/1078-0432.CCR-16-2054","article-title":"Characterization of an abiraterone ultraresponsive phenotype in castration-resistant prostate cancer patient-derived xenografts","volume":"23","author":"Lam","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2025.101181_bib0037","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/0008-5472.CAN-08-2764","article-title":"Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer","volume":"69","author":"Hu","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2025.101181_bib0038","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1158\/0008-5472.CAN-08-3760","article-title":"Androgen receptor controls EGFR and ERBB2 gene expression at different levels in prostate cancer cell lines","volume":"69","author":"Pignon","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2025.101181_bib0039","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1177\/1947601910385450","article-title":"Androgen receptor regulation of vitamin D receptor in response of castration-resistant prostate cancer cells to 1alpha-hydroxyvitamin D5 - a calcitriol analog","volume":"1","author":"Mooso","year":"2010","journal-title":"Genes. Cancer"},{"key":"10.1016\/j.neo.2025.101181_bib0040","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0022-5347(05)67867-6","article-title":"Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer","volume":"163","author":"Xu","year":"2000","journal-title":"J. Urol."},{"key":"10.1016\/j.neo.2025.101181_bib0041","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nature06024","article-title":"Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer","volume":"448","author":"Tomlins","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neo.2025.101181_bib0042","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1158\/0008-5472.CAN-08-3633","article-title":"Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth","volume":"69","author":"Takayama","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2025.101181_bib0043","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.canlet.2005.12.027","article-title":"Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo","volume":"244","author":"Chen","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neo.2025.101181_bib0044","doi-asserted-by":"crossref","first-page":"W305","DOI":"10.1093\/nar\/gkp427","article-title":"ToppGene Suite for gene list enrichment analysis and candidate gene prioritization","volume":"37","author":"Chen","year":"2009","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.neo.2025.101181_bib0045","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ijc.2910570319","article-title":"Derivation of androgen-independent shuman LNCaP prostatic cancer cell sublines: role of bone stromal cells","volume":"57","author":"Wu","year":"1994","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.neo.2025.101181_bib0046","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1038\/emboj.2011.158","article-title":"The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis","volume":"30","author":"Massie","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.neo.2025.101181_bib0047","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.molcel.2007.05.041","article-title":"A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth","volume":"27","author":"Wang","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neo.2025.101181_bib0048","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10020257","article-title":"FAM111A Is a novel molecular marker for oocyte aging","volume":"10","author":"Yang","year":"2022","journal-title":"Biomedicines."},{"key":"10.1016\/j.neo.2025.101181_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114183","article-title":"Adjustment for imbalances in baseline characteristics in the MAGNITUDE phase 3 study confirms the clinical benefit of niraparib in combination with abiraterone acetate plus prednisone in patients with metastatic prostate cancer","volume":"209","author":"Roubaud","year":"2024","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.neo.2025.101181_bib0050","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1001\/jamaoncol.2024.3074","article-title":"Olaparib without androgen deprivation for high-risk biochemically recurrent prostate cancer following prostatectomy: a nonrandomized controlled trial","volume":"10","author":"Marshall","year":"2024","journal-title":"JAMa Oncol."},{"key":"10.1016\/j.neo.2025.101181_bib0051","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12672-013-0152-z","article-title":"On the origins of the androgen receptor low molecular weight species","volume":"4","author":"Mudryj","year":"2013","journal-title":"Horm. Cancer"},{"key":"10.1016\/j.neo.2025.101181_bib0052","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1045455","article-title":"Nucleolar stress: friend or foe in cardiac function?","volume":"9","author":"Yan","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.neo.2025.101181_bib0053","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050803","article-title":"FAM111A induces nuclear dysfunction in disease and viral restriction","volume":"22","author":"Nie","year":"2021","journal-title":"EMBo Rep."},{"key":"10.1016\/j.neo.2025.101181_bib0054","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.cell.2018.07.015","article-title":"Nuclear pores promote lethal prostate cancer by increasing POM121-driven E2F1, MYC, and AR nuclear import","volume":"174","author":"Rodriguez-Bravo","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.neo.2025.101181_bib0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136676","article-title":"Nuclear export inhibitor KPT-8602 synergizes with PARP inhibitors in escalating apoptosis in castration resistant cancer cells","volume":"22","author":"Uddin","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neo.2025.101181_bib0056","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12943-020-01167-9","article-title":"PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications","volume":"19","author":"Zhu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.neo.2025.101181_bib0057","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nature03443","article-title":"Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase","volume":"434","author":"Bryant","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neo.2025.101181_bib0058","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.molcel.2015.10.032","article-title":"Structural basis of detection and signaling of DNA single-strand breaks by Human PARP-1","volume":"60","author":"Eustermann","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neo.2025.101181_bib0059","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1158\/0008-5472.CAN-12-2753","article-title":"Trapping of PARP1 and PARP2 by clinical PARP inhibitors","volume":"72","author":"Murai","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2025.101181_bib0060","doi-asserted-by":"crossref","DOI":"10.3390\/cells13020191","article-title":"Regulating androgen receptor function in prostate cancer: exploring the diversity of post-translational modifications","volume":"13","author":"Lumahan","year":"2024","journal-title":"Cells"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625000600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625000600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:33:35Z","timestamp":1762547615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558625000600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":60,"alternative-id":["S1476558625000600"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2025.101181","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alteration in expression and subcellular localization of the androgen receptor- regulated FAM111A protease is associated with emergence of castration resistant prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2025.101181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101181"}}